DIGEST BEST New
Natural health product licensed in Canada
- Licence holder
- Enerex Botanicals Ltd.
- NPN or DIN-HM
- 80051440
- Status
- Active licence
- Licence date
- 4 June 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 1.67 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 50 FCC AGU | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 15.79 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 12,633 FCC HUT | Not calculated |
| L-Glutamine Source : L-Glutamine | 100 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 10.48 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 5,356 FCC HUT | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 3 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 300 FCC LU | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 4.74 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 4,737 FCC PU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 2.78 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 500 FCC CU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1.33 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 53.33 FCC LU | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 0.5 mg | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 100 FCC SU | Not calculated |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Chlorhydrate de bétaine | 150 mg | Not calculated |
| Diastase du malt Source : Aspergillus niger - En entier | 16.67 mg | Not calculated |
| Diastase du malt Source : Aspergillus niger - En entier | 150 FCC DU | Not calculated |
Non-medicinal ingredients
triglycérides à chaînes moyennes, Hydroxypropylméthylcellulose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Digestive aid. Helps digest proteins. Helps reduce gas production/flatulence following meals rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Helps to prevent gastrointestinal intolerance of oligosaccharides/ fermentable carbohydrates.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051440
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.